Recent shifts in global governance: implications for the response to non-communicable diseases. by Sridhar, Devi et al.
Sridhar, D; Brolan, CE; Durrani, S; Edge, J; Gostin, LO; Hill, P;
McKee, M (2013) Recent Shifts in Global Governance: Implications
for the Response to Non-communicable Diseases. PLoS medicine, 10
(7). ISSN 1549-1277 DOI: 10.1371/journal.pmed.1001487
Downloaded from: http://researchonline.lshtm.ac.uk/1229225/
DOI: 10.1371/journal.pmed.1001487
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Policy Forum
Recent Shifts in Global Governance: Implications for the
Response to Non-communicable Diseases
Devi Sridhar1,2*, Claire E. Brolan3, Shireen Durrani2, Jennifer Edge2, Lawrence O. Gostin4, Peter Hill3,
Martin McKee5
1 School of Social and Political Sciences, University of Edinburgh, Edinburgh, United Kingdom, 2 Blavatnik School of Government, University of Oxford, Oxford, United
Kingdom, 3 School of Population Health, University of Queensland, Brisbane, Australia, 4O’Neill Institute for National and Global Health Law, Georgetown University,
Washington, D.C., United States of America, 5 European Observatory on Health Systems and Policies, London School of Hygiene and Tropical Medicine, London, United
Kingdom
Introduction
As the 2010 Global Burden of Disease
study confirmed, non-communicable dis-
eases (NCDs) (primarily cardiovascular
disease, cancer, chronic respiratory disease,
and diabetes) are now the major cause of
death and disability across the world [1]. In
1990, 47% of disability-adjusted life years
worldwide were attributable to communi-
cable, maternal, neonatal, and nutritional
deficits, 43% to NCDs, and 10% to injuries.
By 2010, this had shifted to 35%, 54%, and
11%, respectively. Over 80% of NCD-
related deaths occur in low- and middle-
income countries, with lower socio-eco-
nomic groups the worst affected in terms of
morbidity, mortality, and loss of economic
opportunity [2]. These figures do not
account for the health and economic
burdens of the wide range and prevalence
of mental health conditions, which are seen
by many as leading NCDs.
The increasing importance of NCDs
has several implications for development.
First, unlike most acute infectious diseases,
the often chronic and debilitating course
of NCDs impedes social and economic
development, deepening inequalities, and
initiates a cycle of disability and health
costs-related poverty [3,4]. Second, as
most NCDs share common major risk
factors and present similar challenges for
clinical management, an integrated re-
sponse is required, avoiding the health
care ‘‘silos’’ that have arisen as a conse-
quence of the narrow focus on HIV,
malaria, and tuberculosis (TB) by interna-
tional donors: well-funded projects that
operate in isolation from national health
systems may fail to address wider health
care needs [5,6].
Fifteen years ago, in the wake of rising
concerns over the lack of progress in
reducing global poverty, all 189 UN
Member States committed themselves to
eight goals aimed at reducing poverty [7].
Yet despite the evidence of a strong
association between NCDs and develop-
ment, these diseases and their shared risk
factors were not included in the Millenni-
um Development Goals (MDGs) [8].
As the 2015 deadline for achieving the
MDGs approaches, a new development
agenda is being mapped out to advance
the progress made towards the MDGs
while addressing remaining gaps and
meeting the complex political and eco-
nomic governance challenges of the post-
2015 landscape. Will the new sustainable
development goals (SDGs) be able to
respond effectively to the rising tide of
NCDs? In this paper we examine three
major trends in global governance and
their implications for post-2015 progress
relating to NCDs.
Trend 1: Rise of the Emerging
Economies
As we move into the second decade of
the 21st century, global power is shifting
yet again, two decades after the changes
that followed the collapse of the USSR.
The power of a few rich countries (notably
the USA, United Kingdom, Germany,
and France) to shape the global agenda is
being challenged by the growing economic
power, of what have been termed the
BRICS countries (Brazil, Russia, India,
China, and South Africa) and the so-called
CIVETs (Colombia, Indonesia, Vietnam,
Egypt, and Turkey).
What does this mean for NCDs? On the
one hand, NCDs are rising on the agendas
of established international bodies. In
2011 the United Nations held a High
Level Meeting on NCDs, only the second
time that it had elevated health to this level
[9]. The first such meeting was on HIV/
AIDS, following which the G8 took up the
torch, creating new institutions such as the
Global Fund to Fight AIDS, Tuberculosis
and Malaria, and prioritizing certain issues
such as universal access to anti-retrovirals.
Yet it is not clear whether the High Level
Meeting on NCDs, which was driven by a
group of small countries, many in the
Caribbean, will lead to similarly sustained
action. Moreover, the G8 have not
considered global health in either their
2011 or 2012 agendas [10] although the
2010 G8 meeting did result in the
Muskoka Accord for maternal health. To
the extent that health will feature on the
G8’s 2013 agenda, it is likely to be in the
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context of liberalization of trade in health
services. Although the locus of global
decision-making is considered to be shift-
ing from the G8 to the G20, it is not clear
that the latter body is willing to assume
even the limited interest in global health
governance seen with the G8 [11], despite
hopes from the health community that it
would do so [12]. Moreover, it is not
apparent from their previous engagement
in global health debates that newer G20
states have a major interest in NCDs.
Thus, having more emerging economies at
the table does not necessarily mean clearer
articulation of an effective NCD response.
Health has also been largely absent
from the agendas of the BRICS countries,
now forming a semi-official grouping.
While they are increasingly influential in
finance and trade, they have had only
limited influence thus far in global health.
The fact that the relatively economically
stable BRICS have not stepped up their
commitments to the Global Fund, the
GAVI Alliance, or WHO has raised
questions about their commitment to
global health leadership in the long term
(Table 1) [13–19]. Domestically, Russia
and to a lesser extent China, are the only
two BRICS countries as of yet to address
NCDs in a substantive manner.
There is some evidence of global health
achieving a higher priority elsewhere,
exemplified by the Foreign Policy and
Global Health Initiative, which draws its
leadership largely from the South and
consists of five Southern (Brazil, Indonesia,
Mexico, Senegal, and Thailand) and two
Northern (France and Norway) countries.
Yet, with the exception of the Caribbean
Community (CARICOM) [20], it is un-
certain whether the rise of newly emerging
economies will mean global engagement
with NCDs.
In summary, although emerging econo-
mies are clearly influential in global gover-
nance, there is little evidence of commit-
ment to the NCD agenda, and it does not
follow that they will advance the interests of
poorer countries—or even health. To the
extent that these countries do engage in
health, it has been issue-specific, such as on
access to essential medicines, technological
cooperation, or on Trade-Related Aspects
of Intellectual Property Rights (TRIPs)—all
areas where health is incidental to trade
concerns. Furthermore, global health en-
gagement by emerging powers is often
driven by regional concerns, which explains
the re-invigoration and creation of regional
bodies in health, particularly in Latin
America. In this changing environment
there is a danger of health slipping off the
agenda of the traditional economic and
political powers but not being taken up by
the emerging ones.
Trend 2: Rise (and Fall) of Multi-
bi Financing
Over the past decade, most of the growth
in multilateral funding has been through
the channel of ‘‘multi-bi aid’’ [21]. This
refers to the practice of donors choosing to
route non-core funding, earmarked for
specific sectors, themes, countries, or re-
gions, through multilateral agencies. At first
glance the funding looks multilateral, but
upon closer inspection, it is essentially
bilateral. Examples of multi-bi aid include
voluntary contributions within the WHO,
trust funds within World Bank, the Global
Fund, and the GAVI Alliance. Since 2002,
global health donors have increasingly
prioritized multi-bi aid at the expense of
more traditional forms of multilateral aid as
a proportion of all development assistance
for health [22]. Multi-bi aid increased as a
proportion of all aid at a rate of approxi-
mately 1.5–2.0 percentage points per year
over this time period [22].
The rise of multi-bi aid has three
implications for the NCD agenda. First,
an analysis of the WHO’s expenditures
shows a significant misalignment with the
burden of disease, both globally and at
regional levels, with the additional volun-
tary resources least well aligned [23]. In
2008–2009 of the WHO’s regular budget,
25% of funds were allocated to infectious
disease, 8% for NCDs, and roughly 4.7%
for injuries, which when compared with
the global distribution of DALYs noted
Summary Points
N Despite evidence of links between non-communicable diseases (NCDs) and
development, these diseases and their risk factors were not included in the
Millennium Development Goals (MDGs).
N Three major trends in global governance—the rise of emerging economies, the
increase in multi-bi financing, and institutional proliferation—have implications
for whether NCDs will be included in the post-2015 Sustainable Development
Goals (SDGs) agenda.
N While emerging economies are influential in global governance, it is not clear
that the interests of poorer countries—or even health—will be advanced.
N If NCDs are included in the new health goals, it likely will be via the broad
umbrella of healthy life expectancy (HLE), or the sector-specific target of
universal health coverage (UHC) or access.
N UHC or HLE as currently conceived are unlikely to adequately incorporate NCDs
that require alternative health system mechanisms and clear governmental
intervention.
Table 1. BRIC financial contribution to key global health institutions and amount received from Global Fund and GAVI [14–19].
Country
Global Fund
Contributions
(Cumulative to
End 2012, $US
Millions)
Global Fund
Amount Received
(Cumulative to
Date, $US Millions)
GAVI Contributions
(Cumulative to 2012,
$US Millions)
GAVI Amount
Received (Cumulative
to 2012, $US Millions)
WHO Core
Contributions
(2012, $US
Millions)
WHO
Extrabudgetary
Contributions ($US
Millions)
Brazil 0.0 39.1 0.0 0.0 7.5 0.03
Russia 297.0 372.0 24.0 0.0 7.4 6.1
India 10.0 1,019.9 0.0 94.0 2.5 0.015
China 25.0 763.3 0.0 38.7 14.8 0.4
S. Africa 10.3 350.6 6.0 0.0 1.8 0.0
doi:10.1371/journal.pmed.1001487.t001
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above indicates a disproportionate share of
resources going to the first of these at the
expense of the remaining two. However,
the WHO’s extra-budgetary funding for
2008–2009 is even further out of align-
ment, with 60% allocated primarily to
infectious diseases, while only 3.9% was
used for NCDs and 3.4% for injuries.
Second, the emergence of new multi-
stakeholder global health funding institu-
tions such as the Global Fund and the
GAVI Alliance has signaled a major shift in
global cooperation, one in which voting
rights and board membership is granted to
the private sector and philanthropic orga-
nizations and legitimacy is claimed through
improving specific measurable health out-
comes [21]. Given the aggressive tactics the
tobacco, alcohol, and food industries have
used to oppose regulation addressing key
NCD risk factors, it will be difficult to have
industry at the table while addressing the
root causes of the pandemic [24].
Third, an analysis by Grepin and
Sridhar shows that the movement towards
multi-bi aid reversed since the onset of the
global financial crises with donors decreas-
ing their contributions to the GAVI
Alliance, the Global Fund, and UNAIDS
since 2008 [22]. This is particularly true of
the ten largest global health donors, where
this channel of funding decreased by
nearly 6% of all development assistance
for health during 2008–2009. Thus, it is
unlikely that in the current financial
climate new funds will be available to
address NCDs. Given this situation, na-
tional governments will have to bear
almost all the costs of responding to NCDs
and will have little external incentive to
prioritize these diseases [25].
Trend 3: Institutional
Proliferation
Since 2000, more and more global
health institutions and initiatives have been
created such as the GAVI Alliance, the
Global Fund, and the Global Alliance for
Improved Nutrition. However, they remain
largely uncoordinated, focused on vertical
disease-specific programs, and lack rigorous
assessment [26,27]. Initiatives designed to
support coherence among global players
such as the International Health Partner-
ship (IHP+) and Health 8 (H8) have
remained largely focused on vertical global
health program delivery rather than taking
a role in leading governance for health as a
global public good [28].
This institutional proliferation has two
implications for the future NCD agenda.
First, only a handful of these actors are
interested in or focusing on the drivers of
the NCD epidemic. According to the
Institute for Health Metrics and Evalua-
tion, only US$185 million of the US$28.2
billion spent globally on development
assistance for health in 2010 was dedicated
to NCDs [29]. Donors spent US$300 for
each year lost to disability from HIV/
AIDS, US$200 for malaria, and US$100
for TB, but less than US$1 for NCDs.
Nearly half of the development assistance
for NCDs in 2010 derived from a single
source: the Bloomberg Family Foundation
[30].
Second, the drivers of NCDs are
intricately connected with the policies of
non-health sectors [30]. Multi-sector par-
ticipation has already begun on health
issues at the state-level through inter-
ministerial working groups focused on
global health, the reduction of health
inequities, and HIV/AIDS prevention in
Australia, Canada, India, Norway, Swe-
den, Switzerland, Thailand, Uganda,
United Kingdom, and United States [31–
33]. Institutional incentive structures to
engage other sectors in negotiations about
health are crucial to raising the profile of
health-related priorities in other policy
communities at the all levels of gover-
nance. However, the WHO and other
global health agencies presently lack the
resources and mechanisms to meaningfully
participate in policy issues like trade,
agriculture, security, and climate change
[29].
Post-2015: Universal Health
Coverage and Healthy Life
Expectancy
If NCDs are to be included in the new
health goals, it seems most likely to be
through the the sector-specific target of
universal health coverage (UHC) or access
or the broad umbrella of healthy life
expectancy. UHC has received particular
prominence recently (Box 1). In January
2012, the Bangkok Statement on UHC
committed to ‘‘raise universal health
coverage on the national, regional and
global agendas, and to advocate the
importance of integrating it into forthcom-
ing United Nations and other high-level
meetings related to health or social
development’’ [34]. In April 2012 the
Mexico City Political Declaration on
UHC emphasized universal coverage as
‘‘an essential component of sustainable
development’’ and its inclusion ‘‘an im-
portant element in the international de-
velopment agenda’’ [35]. In June 2012 the
Rio+20 resolution explicitly recognized
UHC, seeking ‘‘to strengthen health
systems towards the provision of equitable
universal coverage’’ [36]. Later in 2012, a
WHO Discussion Paper on the Post 2015
health agenda, identified UHC as a ‘‘way
of bringing all programmatic interests
under an inclusive umbrella’’ [37]. On
12 December 2012 UHC received un-
equivocal endorsement from the UN
General Assembly (including the United
States) in approving a resolution on UHC,
confirming the ‘‘intrinsic role of health in
achieving international sustainable devel-
opment goals’’ [38].
As the above developments indicate, the
post-2015 health discussions have been
centered on UHC and its link to WHO’s
revitalization of Primary Health Care. In
our opinion, this enthusiasm has been
tempered by confusion as to what UHC
actually is, as well as the fear of failure
from previous attempts such as ‘‘Health
for All.’’ For example, in 2005 the World
Health Assembly officially defined the
achievement of UHC as ‘‘access to key
promotive, preventive, curative and reha-
bilitative health interventions for all at an
affordable cost, thereby achieving equity
in access’’ [39]. Yet, elsewhere, UHC has
been construed as national service deliv-
ery, national service coverage, financial
protection, and national health insurance
and related reforms. We believe that it is
unclear what health services UHC covers
(e.g., whether it fully covers public health
services such as sanitation, vector abate-
ment, and tobacco control), and questions
arise over whether UHC includes only
services within a state’s health sector or
services and interventions outside the
health sector [40,41].
If UHC is to become a new develop-
ment goal, we argue that baselines for
achievement of UHC must be agreed and
developed in post-MDG negotiations and
adapted to country circumstance, fiscal
realities, and community priority. Cur-
rently it is not clear that policy-makers
have considered how to integrate the
response to NCDs with the scaling up of
basic care through strengthening primary
health care. For example, the USSR was
successful in scaling up measures against
infectious diseases, but failed to tackle the
key drivers of NCDs [42]. Most impor-
tantly, we feel that UHC will have limited
impact on the rising tide of NCDs without
targets and funding to reduce risk fac-
tors—requiring a prevention, public
health, and ‘‘all of society’’ approach.
Recent discussions in Botswana high-
light a move towards the broad umbrella
of healthy life expectancy (HLE), or
‘‘maximizing healthy lives,’’ measured as
‘‘reducing healthy years of life lost’’ [43].
But will HLE result in a better response to
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NCDs? Civil society organizations have
started to champion HLE as the best vehicle
to address the social determinants of health,
thus creating space to address the root
causes of the NCD crisis. On the other
hand, HLE could also be used to push for
individual responsibility for health and
reframing unhealthy behaviors as personal
choices, ignoring the circumstances within
which those choices are made. HLE also
makes it harder to tie health outcomes to
state or institutional responsibility. Thus,
could NCDs be addressed in such health
goals? At face value, yes. But it is not clear in
our view whether UHC or HLE as currently
conceived will adequately incorporate the
prevention and treatment of NCDs, which
require alternative health system mecha-
nisms and clear responsibility placed on the
state for ensuring a healthy environment.
Conclusion
In the post-2015 debate, almost no
attention has been given to the global
governance structures necessary to support
the attainment of the new goals. It is
generally agreed that we need 21st-century
innovative structures that go beyond the
WHO ‘‘command and control’’ model,
but little detail is given on institutional
responsibility, monitoring, and evaluation
Box 1. Political History of UHC.
Date Event
1975 Health for All. (WHO)
1978 Declaration of Primary Health Care, Alma Ata. (WHO/UNICEF)
1987 Bamako Initiative on Health Financing. (UNICEF/WHO)
1993 World Development Report 1993: Investing in Health. (World Bank)
2000 World Health Report 2000. Health systems: Improving performance. (WHO)
2000 UN Millennium Declaration
2001 Adoption of Millennium Development Goals
2002 Commission on Macro-Economics and Health. (WHO)
2005 Paris Declaration on Aid Effectiveness. (OECD-DAC)
2005 GAVI Alliance Health Systems Funding Window. (GAVI)
2006 Global Fund to fight AIDS, TB and Malaria Health Systems Funding Window. (Global Fund)
2007 International Health Partnerships Plus (IHP+)
2007 Everybody’s Business. Strengthening Health Systems to Improve Health Outcomes. WHO’s Framework for
Action. (WHO)
2007 Inaugural meeting of H8 (Health 8)
2008 World Health Report 2008. Primary Health Care: Now more than ever. (WHO)
2008 G8 Commitment to strengthening Health Systems, Toyako.
2009 High Level Taskforce on Innovative Financing for Health Systems
2009 Health Systems Funding Platform. (Global Fund/GAVI/World Bank/WHO)
2010 World Health Report 2010. Health systems financing: The path to universal coverage. (WHO)
2010 1st Global Symposium on Health Systems Research, Montreux.
2011 Universal Health Coverage, WHO General Assembly
2012 Bangkok Statement on Universal Health Coverage, Prince Mahidol Award Conference
2012 Mexico International Forum on Universal Health Coverage. (WHO)
2012 2nd Global Symposium on Health Systems Research, Beijing.
2012 UN General Assembly: Universal Health Coverage declared a UN global goal.
2013 World Health Report 2013. Research for universal health coverage. (WHO)
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and accountability [44]. For NCDs in
particular, the global response requires
more than new funding or financing
mechanisms. It requires global regulation
of the key vectors of the epidemic, as well
as linkages between health and the other
areas discussed as part of the SDGs
agenda such as agriculture and food
security, environment, trade, urban devel-
opment, energy policies, education, pov-
erty alleviation, and gender equity. This
necessity points to both the key role of the
WHO as well as the inherent limitation in
making the agency the focal point for the
response. The WHO is the only global
health body with the power to create
international law, and given its success in
legislating against tobacco (The Frame-
work Convention on Tobacco Control),
similar ‘‘hard law’’ mechanisms for other
main drivers of the NCD epidemic such as
alcohol and processed food are certainly
feasible [45]. At the same time, for multi-
sectoral convergence to become a reality,
various agencies of the UN must act in
concert to catalyze, support, and monitor
such collaboration [9].
While the epidemiological evidence is
clear on the rising burden of NCDs across
geographic boundaries, the current post-
2015 discussions and larger global gover-
nance trends create challenges to address-
ing this burden effectively. These political
and economic influences need to be
considered carefully if NCDs are not to
be left behind again.
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